Navigation Links
Cardiome Announces Investigational Candidate, Vernakalant, Meets Primary Endpoint in European Comparator Study
Date:12/17/2009

NASDAQ: CRME TSX: COM

VANCOUVER, Dec. 17 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that the recently-completed Phase 3 European Comparator Study (the AVRO study) evaluating vernakalant (iv) versus amiodarone for the acute conversion of atrial fibrillation met its primary endpoint.

The AVRO study achieved statistical significance in demonstrating the superiority of vernakalant (iv) over amiodarone in the conversion of atrial fibrillation to sinus rhythm within 90 minutes of the start of drug administration. Overall the data suggests that vernakalant (iv) was well-tolerated in the study population. There were no vernakalant-related deaths or cases of "Torsades de Pointes", a specific and well-characterized ventricular arrhythmia.

Cardiome expects that detailed results of this study will be presented at a scientific conference in 2010.

In April 2009, Cardiome and Merck & Co., Inc. announced a collaboration and license agreement for the development and commercialization of vernakalant, an investigational candidate for the treatment of atrial fibrillation. The agreement provides a Merck affiliate, Merck Sharp & Dohme Corp., with exclusive global rights to vernakalant (oral) for the maintenance of normal heart rhythm in patients with atrial fibrillation, and provides another Merck affiliate, Merck Sharp & Dohme (Switzerland) GmbH, with exclusive rights outside of the United States, Canada and Mexico to vernakalant (iv) for rapid conversion of acute atrial fibrillation to normal heart rhythm. If approved by the European regulatory authorities, Merck has exclusive rights to commercialize vernakalant (iv) in the European Union.

'/>"/>
SOURCE Cardiome Pharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Cardiome to Release Third Quarter Results
2. Cardiome And Astellas Announce Initiation Of Patient Enrolment In ACT 5 Trial
3. Orexigen(R) Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk
4. Cardiome Pharma Corp. Announces Final Results of Tender Offer
5. Cardiome Pharma Corp. Announces Commencement of US$27.5 Million Tender Offer
6. Cardiome Announces Upcoming Presentation Of Results Of Phase 2b Clinical Trial Of Vernakalant (Oral) At The European Society Of Cardiology Congress 2009
7. Cardiome Pharma Corp. Announces Tender Offer To Purchase Up To US$27.5 Million Of Its Common Shares
8. Atherotech Adds New Cardiometabolic Tests Amid Strong 2009 Growth
9. Cardiome to Hold Conference Call
10. Cardiome Announces Management Transition
11. Cardiome Achieves Milestone From Collaboration With Merck Co., Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Pain Free Living web: Superior ... pain relief and improved performance. This new magnetic sports ... a silicone core that is sheathed in nylon soaked ... embedded with scalar energy and Schumann frequency thus making ... has 12 years experience developing magnetic bracelets. We developed ...
(Date:7/30/2014)... Nuanced Media, a specialist in web design ... the Medical Web Design Trends of 2014. The web ... multiple agencies and the medical web design industry throughout the ... the industry grows. Therefore it is important for existing practices ... enjoy most. New trends are defined by advances in the ...
(Date:7/29/2014)... Paul Mata, CEO of ‘Create Indestructible Wealth,’ ... 30 Days” E-book. The e-book includes a myriad of fast ... cash. Examples include downloading and utilizing specific phone apps ... people monetize the assets they didn't know they had like ... find in their garage. , After reading the e-book, ...
(Date:7/29/2014)... MO (PRWEB) July 30, 2014 ... have recently been awarded the Patient-Centered Medical Home ... the National Committee for Quality Assurance. Only one ... NCQA Level I, Level 2, or Level 3 ... participate in Patient-Centered Medical Home report faster access ...
(Date:7/29/2014)... 29, 2014 1Heart Caregiver Services’ ... with focus on Brain Fitness Education brings great ... Brain Fitness Program Director Tee Barr delivered an ... Care unit and the Assisted Living section of ... Enrichment Director Christy Rozsa and Aegis Life Neighborhood ...
Breaking Medicine News(10 mins):Health News:Superior Magnetics Released New Magnetic Sports Bracelet for Pain 2Health News:Nuanced Media Releases "Medical Web Design Trends of 2014" Article 2Health News:Create Indestructible Wealth Launches Innovative E-Book: “Realistic Ways to Make More Money in 30 Days” 2Health News:Saint Luke’s Medical Group Awarded Patient-Centered Medical Home 2011 Level 3 Recognition 2Health News:1Heart Caregiver Services Conducts Brain Fitness Education and Brings Tee Barr to Aegis Ventura 2Health News:1Heart Caregiver Services Conducts Brain Fitness Education and Brings Tee Barr to Aegis Ventura 3Health News:1Heart Caregiver Services Conducts Brain Fitness Education and Brings Tee Barr to Aegis Ventura 4
... research has pointed out the increasing problem of super bugs ... ,Super bugs are a new kind of microorganisms, mainly ... wide range of antibiotics. ,The researchers of Fogarty International ... blame the use of antibiotics in agricultural farms for creating ...
... A study published in the July edition of the ... // number and severity of cases of constriction of ... ,Normally constriction of blood vessels occurs ... to strokes and neurological deficits. This can cause not ...
... In an article in the recent issue of the ... and smoking. ,Researchers have looked into the data ... a firm connection between smoking and incidence of tuberculosis ... them tested positive for tuberculin skin test. The research ...
... an important component of mammal’s daily life and more so of ... known to sleep for over 18 hours. However, it is different ... been reported in Nature that newborn bottlenose dolphins and killer whales ... moms manage with only a wink or two than the newborns. ...
... The July issue of the health journal Epidemiology has published ... of cancer are higher if there is associated infertility. ... Rockville, Maryland, and her team followed 12,193 U.S. women ... risk among infertile women with that of the general population. ...
... the womb of the mother, may have asthma at a ... an 11-year observation of incidence of asthma and other respiratory ... to incidence of asthma in childhood. Passive smoking by the ... of asthma in children. ,Researchers are of the opinion ...
Cached Medicine News:Health News:Clazosentan May help to Improve Blood Circulation after Brain Hemorrhage due to burst Aneurysm 2
(Date:7/29/2014)... , July 29, 2014 Numotion,s Board of Directors ... Swinford will be the company,s new Chief Executive Officer. ... 22-year career at GE where he worked primarily for GE ... revenue to over $5 billion. His most recent position was ... "I am thrilled to join Numotion," said ...
(Date:7/29/2014)... NEW YORK , July 29, 2014 ... and services for the science, technical, and medical communities, ... , the first off-line mobile application of the world-renowned ... of the new AccessMedicine App , available for ... users will now be able to gain access to ...
(Date:7/29/2014)... 29, 2014  Neurocrine Biosciences, Inc. (Nasdaq: ... its second quarter 2014 financial results after the Nasdaq ... then host a live conference call and webcast to ... Thursday morning, August 7, 2014 at 8:00 a.m. Eastern ... access the live conference call by dialing 866-952-1907 (US) ...
Breaking Medicine Technology:Numotion Names Mike Swinford CEO 2McGraw-Hill Education Professional's AccessMedicine App Delivers Instant Access to Essential Diagnostic Tools 2McGraw-Hill Education Professional's AccessMedicine App Delivers Instant Access to Essential Diagnostic Tools 3Neurocrine Biosciences Announces Conference Call And Webcast To Report Second Quarter 2014 Financial Results 2
... BILLERICA, Mass., May 7, 2011 Objet Geometries Ltd. ... rapid prototyping and additive manufacturing, will demonstrate the ... LAB DAY West. Exhibiting at Booth B6, B-7, Objet will ... throughout the show on the Objet Eden260V™ 3D printing system. ...
... PRINCETON, N.J., May 6, 2011 Covance Inc. (NYSE: ... Baird,s 2011 Growth Stock Conference on Tuesday, May 10, 2011 ... of the presentation at www.covance.com .  In order to ... minutes early. Covance, with headquarters in Princeton, New ...
Cached Medicine Technology:Objet to Showcase Exceptionally Detailed and Accurate Dental Models at LMT LAB DAY West 2Objet to Showcase Exceptionally Detailed and Accurate Dental Models at LMT LAB DAY West 3Objet to Showcase Exceptionally Detailed and Accurate Dental Models at LMT LAB DAY West 4Covance to Present at Baird's 2011 Growth Stock Conference 2
... Injection is supplied in an isotonic solution ... intravenous administration. Each milliliter contains 37 megabecquerels ... calibration time, made isotonic with 9 milligrams ... benzyl alcohol. The pH is adjusted to ...
... single-detector system offers general purpose ... for gurneys and wheelchairs. This ... versatile open gantry, caudal/cephalic detector ... for SPECT and whole body ...
Stainless steel lancet blade in stainless steel....
Sharp diamond shaped double blade in stainless steel....
Medicine Products: